GLOBUS MEDICAL INC (GMED)
GLOBUS MEDICAL INC (GMED) from its SEC filings: 2025 revenue $2.9 billion (+17% vs the year before), net margin 18%, free cash flow $588.8 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $2.9 billion |
| Revenue growth | +17% |
| Net income | $537.9 million |
| Net margin | 18.3% |
| Free cash flow | $588.8 million |
| Diluted EPS | $3.92 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +6% |
| Cash | $507.7 million |
| Share count, 1 year | -1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.